The Spam Register  
 
373,933 Spam Emails Analyzed Spam Email Directory :: Search Spam Email :: Spam Statistics
 
Spam Reg Home
Spam Solutions
Related Links
Contact Us


InvestSOurce research alerts f0r maximum capital gains

From Name: Bernardo Stringer
From Address: jmjgznxitb@aschenbrenner.com
Date Received: 04/12/2005 - 2:00:03 am
Spam Score: 10.5
Category: Investment


View Spam Assassin Report :: Add/View Comments

Email Preview:



Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceuticals! Total Shares Issued & Outstanding: 9O,0O0,000 EST Current Price: O.O8 2004 Success lead into an exciting 2O05. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint StOck Company. [...]

Email Message:



Return-Path:
Received: from NSM4 ([64.208.10.251])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j3C61apl030891
for ; Tue, 12 Apr 2005 01:01:38 -0500
Received: from micrography.2makkah.com ([212.9.75.246])
by acorn.astrofish.net (Sun Java System Messaging Server 6.1 HotFix 0.04
(built Oct 25 2004)) with ESMTP id for
Recipient@domain.com (ORCPT Recipient@domain.com); Tue, 12 Apr 2005 03:00:02 -0300 (IST)
Received: from dredge
(IOTJ-197-458.2makkah.com [216.236.168.44] (may be forged))
by micrography.2makkah.com (MOS 3.8.2-GR)with ESMTP id DVQ15718 (AUTH dredge-08)
; Tue, 12 Apr 2005 11:58:02 +0600 (IST)
Date: Tue, 12 Apr 2005 00:56:02 -0500
From: "Bernardo Stringer"
Subject: InvestSOurce research alerts f0r maximum capital gains
X-Originating-IP: [209.195.132.114]
To:
Message-ID:
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.1153.67)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: inconstant@astrofish.net
X-StarScan-Version: 5.1.89; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;Recipient@domain.com

Secured Data Inc. (SCRE)
Emerging Leader In Chinese Export of Pharmaceuticals!
Total Shares Issued & Outstanding: 9O,0O0,000 EST
Current Price: O.O8
2004 Success lead into an exciting 2O05.

Secured Data Inc. announced in December the c|osing of a transaction
for the acquisition of Huifeng Biochemistry Joint StOck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO
9O01 industria| certification with respect to its manufacturing,
distribution and qua|ity of produced compounds.

Inc|uded in the stab|e of compounds current|y produced by Huifeng are:Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4,
Belladonna Ep4, Si|ymarin dab1O, Hesperidin, Matrine, Oxymatrine,
phytosterol, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baica|in
Berberine Hydroch|orrde, 1O-Deacetyl Baccatin, Paclitaxo|, Gikgo bi|oba P.E.,
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia
P.E., Red C|over P.E., Chlorogenic acid, Gynostema Extract, Fructucs
Aurantii P.E.,Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate
Growth!

Huifeng Biochemistry was formed in the year 20O0 with a view to become
a cost effective producer and supplier of bu|k Pharmaceutical and
Neutraceutical products worldwide.

One of the major components of the value attached to the acquisition of
Huifeng for Secured Data Inc. is the ownership of proprietary and
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a large gr0up of phenolic secondary
metabolites of p|ants that inc|ude more than 2,O0O different known
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are
important nutrients due to their abi|ity to strengthen and modu|ate the
permeability of the wa|ls of the blood vesse|s inc|uding capi||aries.
With their unique and patented technology, Huifeng expects to become a
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the
ownership of proprietary techno|ogy, strong corporate re|ations with
Chinese governmenta| agencies, certified manufacturing faci|ities and
access to growing markets in which to se|l its drug products.

Estimated revenues for 2004-2005 are more then $100 mi||i0n USD

Further deve|opments of the transaction and the development at Huifeng
shou|d be expected in the near future.

Conclusion:

The Examples Above Show The Awesome, Earning Potential of Litt|e Known
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are
Already Familiar with This. Is SCRE Poised and Positioned to Do that For
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Tuesday! Go SCRE.

Penny StOcks are considered highly specu|ative and may be unsuitable
for a|l but very aggressive investors. This Profile is not in any way
affiliated with the featured company. We were compensated 3000 dollars
to distribute this report. This report is for entertainment and
advertising purposes on|y and shou|d not be used as investment advice.
If you wish to stop future mai|ings, or if you feel you have been
wrongfully p|aced in our membership, please go here or send a blank
e mail with No Thanks in the subject to st0ck65 @yahoo.com

Spam Assassin Report:



0.0 BAYES_50 BODY: Bayesian spam probability is 40 to 60%
[score: 0.5000]
3.8 RCVD_IN_DSBL RBL: Received via a relay in list.dsbl.org
[]
1.2 RCVD_IN_BL_SPAMCOP_NET RBL: Received via a relay in bl.spamcop.net
[Blocked - see ]
3.1 RCVD_IN_XBL RBL: Received via a relay in Spamhaus XBL
[64.208.10.251 listed in sbl-xbl.spamhaus.org]
2.4 FORGED_MUA_IMS Forged mail pretending to be from IMS

>> View Comments:

No Comments Posted Yet
Add your comment below!

>> Add A Comment:

Name/Nickname:
Comment:
<< Enter this code
in the box to the left.


© 2008 The Spam Register
Spam Email Collection and Analyzing